Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Spine Implants:
Porous Coatings vs. Porous Materials vs. Additive Manufacturing

When: Wednesday, June 12 | 3:15 pm - 4:00 pm 
Where: Coatings Tech Center | 
Level: Intermediate, Advanced
Participant Type: Research & Development, Product Development, Regulatory/Clinical Affairs, Quality Control, Manufacturing

viewpresentation

 

Description

Spine implant materials and surface characteristics are popular topics among engineers and surgeons.
In this interactive session, members of industry and academia will review and present research related to use of
     • porous plasma spray coating,
     • porous PEEK, and
     • additive manufactured titanium in spinal devices.

How do surface technologies relate to spine implants and bone integration and fusion? What are the pros and cons of various materials and surfaces? A panel discussion and audience Q&A will follow the presentations.

Takeaways

  • Learn what current research demonstrates about the use of porous coatings, porous materials and additive manufacturing in spine
  • Gain perspective from leading companies and researchers about the future of coatings and surface characteristics in spine implants


Speakers

Moderator

Mukesh Kumar, Ph.D., joined as Global Director of Technology at Surface Dynamics/Eurocoating in 2018, having served 17 years with Biomet and three years with Zimmer Biomet.
He has participated in bringing to market biomaterials such as OsseoTi 3D-printed implants, Regenerex porous constructs, Bonus DBM and porous Calcium Phosphate bone void fillers. Known for his results-oriented and innovative approach, Dr. Kumar has lead NPI and PME engineers to support various business units and R&D scientists to explore new technologies. He is known for making assessments on nascent technology to determine what is needed to from research, regulatory and processing aspects to achieve commercialization.


Panelists


Jason Cianfrani is Vice President of Product Development for IMSE and Camber Spine.
Mr. Cianfrani is a Product Development Engineering and Mechanical Design Team Leader with an inventor/entrepreneurial mindset. He has over 18 years of experience in all facets of product development, manufacturing and marketing. Mr. Cianfrani spent nearly 10 years in product development at Globus Medical, where he grew the cervical fixation division by 40% through the launch of five new products and was instrumental in the launch of several other highly successful products. He is a named inventor on 50+ medical device patents and applications. In his role at IMSE and Camber Spine, Mr. Cianfrani leads a high-performance product development and ideation team. Mr. Cianfrani is a graduate of Clemson University with a Bachelor of Science in Mechanical Engineering.

Ken Gall, Ph.D., is Professor and Chair, Mechanical Engineering and Materials Science at Duke University. Dr. Gall’s research aims to develop a fundamental understanding of the relationship between the processing, structure, and mechanical properties of materials. His scientific contributions range from the creation and understanding of shape memory metals and polymers to the discovery of a new phase transformation in metal nanowires. His current research interests are 3D printed metals and polymers, soft synthetic biomaterials and biopolymers with structured surface porous networks. Dr. Gall is a passionate entrepreneur who founded MedShape and Vertera, both of which have commercialized university based technologies in the orthopedic space.

Byron Masi, Ph.D., is Associate Director R&D Global Alignment, U.S. Innovation at Aesculap.
He began his orthopedic industry career at Smith & Nephew in Andover, Massachusetts, where he was a member of their technology incubator responsible for vetting the technical, clinical and commercial viability of platform technologies. His current responsibilities at Aesculap include ensuring R&D alignment with the global organization and international affiliates. Additionally, he is responsible for the process by which U.S.-only projects are proposed, vetted, approved and monitored.